Candidate Selection and Practice Management Considerations With Anticomplement Therapy for GA

We are no longer at the mercy of the disease, but we must still think about increases in patient volume.

By: Anton Kolomeyer, MD, PhD

Retinal Physician February 7, 2025

1

Anticomplement therapy offers a new treatment option for geographic atrophy (GA), a previously untreatable form of age-related macular degeneration (AMD).
2

Candidate selection for anticomplement therapy is broad, as all patients with GA secondary to AMD are theoretically eligible, regardless of visual acuity or disease characteristics.
3

Patient discussions about anticomplement therapy are crucial, with many opting for treatment based on the status of their fellow eye and potential vision loss.
4

Increased patient volume from GA treatment may strain clinical practices, necessitating adjustments in scheduling, staffing, and resource management.
5

The availability of anticomplement injections for GA is a significant advancement, with hopes for more treatment options in the future.

1